BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28093937)

  • 1. Unmet needs in developing nanoparticles for precision medicine.
    Schwartz S
    Nanomedicine (Lond); 2017 Feb; 12(4):271-274. PubMed ID: 28093937
    [No Abstract]   [Full Text] [Related]  

  • 2. Breaking Down the Barriers to Precision Cancer Nanomedicine.
    von Roemeling C; Jiang W; Chan CK; Weissman IL; Kim BYS
    Trends Biotechnol; 2017 Feb; 35(2):159-171. PubMed ID: 27492049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine and veterinary science: the reality and the practicality.
    Underwood C; van Eps AW
    Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of individualized anti-metastasis strategies by engineering nanomedicines.
    He Q; Guo S; Qian Z; Chen X
    Chem Soc Rev; 2015 Oct; 44(17):6258-86. PubMed ID: 26056688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for Treatment of Lung Cancer.
    Hussain S
    Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine and personalised medicine: understanding the personalisation of health care in the molecular era.
    Noury M; López J
    Sociol Health Illn; 2017 May; 39(4):547-565. PubMed ID: 27782304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine: magnetic nanoparticles hit the target.
    Amirfazli A
    Nat Nanotechnol; 2007 Aug; 2(8):467-8. PubMed ID: 18654342
    [No Abstract]   [Full Text] [Related]  

  • 10. Theranostic nanomedicine for cancer.
    Sumer B; Gao J
    Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines for kidney diseases.
    Williams RM; Jaimes EA; Heller DA
    Kidney Int; 2016 Oct; 90(4):740-5. PubMed ID: 27292222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
    Muthu MS; Singh S
    Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine.
    Sunderland KS; Yang M; Mao C
    Angew Chem Int Ed Engl; 2017 Feb; 56(8):1964-1992. PubMed ID: 27491926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.
    Lepeltier EA; Nuhn L; Lehr CM; Zentel R
    Nanomedicine (Lond); 2015; 10(20):3147-66. PubMed ID: 26447353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine's promising therapy: magnetic drug targeting.
    Kempe H; Kates SA; Kempe M
    Expert Rev Med Devices; 2011 May; 8(3):291-4. PubMed ID: 21542699
    [No Abstract]   [Full Text] [Related]  

  • 19. New perspectives of nanoneuroprotection, nanoneuropharmacology and nanoneurotoxicity: modulatory role of amino acid neurotransmitters, stress, trauma, and co-morbidity factors in nanomedicine.
    Sharma HS; Sharma A
    Amino Acids; 2013 Nov; 45(5):1055-71. PubMed ID: 24022705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
    Psarros C; Lee R; Margaritis M; Antoniades C
    Nanomedicine; 2012 Sep; 8 Suppl 1():S59-68. PubMed ID: 22640906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.